Gaudium IVF Files DRHP for IPO: Details of Share Allocation, Objectives, and Financials
Gaudium IVF and Women Health has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for an Initial Public Offering (IPO). The IPO is a book-built issue and aims to raise funds through a fresh issue of shares and an offer for sale (OFS). The company plans to list on both the super娛樂城 (NSE) and the 娛樂城 (BSE). The IPO date has not yet been announced.
IPO Structure and Share Allocation
The IPO comprises a fresh issue of ?1.83 crore equity shares and an offer for sale of up to 183,544 equity shares with a face value of ?5 each. The allocation of shares is divided into:
- Retail investors: 35%
- Qualified Institutional Buyers (QIB): 50%
- High Net worth Individuals (HNI): 15% Dr. Manika Khanna, a promoter of the company, will be selling stocks in the OFS process.
Company Background
Gaudium IVF and Women Health Limited was established in 2009 by Dr. Manika Khanna. Gaudium IVF is a leading fertility clinic in India dedicated to helping individuals achieve their dreams of parenthood. The company operates across more than 30 locations in India, with 7 hubs and 28 spokes. Gaudium is known for its high success rates, especially in challenging cases. They are also known for putting great emphasis on patient-centric care with customized treatment plans for every client. The facility uses advanced technology, such as the INTEGRA Ti system, to ensure world-class fertility treatment.
Financial Performance
Gaudium IVF and Women Health has shown consistent growth in recent years. The company's profit after tax increased by 22.7% in the fiscal year 2024, reaching ?16.89 crore, compared to the previous year. Revenue also increased by 20.9%, reaching ?53.48 crore during the same period. For the six-month period ending September 2024, the company reported a profit of ?8.28 crore and revenue of ?31.69 crore. The financial data is presented in ? Crores.
Key financial data includes:
2022: Revenue ?36.52, Profit After Tax ?8.83
2023: Revenue ?44.24, Profit After Tax ?13.43
2024: Revenue ?53.48, Profit After Tax ?16.89
Sep 2024: Revenue ?31.69, Profit After Tax ?8.28
Use of IPO Proceeds
The funds raised from the IPO will be utilized for the company's expansion plans, including establishing new IVF centers, investing in its wholly-owned subsidiary EKK Global Pvt Ltd, and launching Fast-Moving Consumer Goods (FMCG) products. Additionally, the company will allocate funds to meet working capital needs and for general corporate purposes.
IPO Management
Sarthi Capital Advisors Private Limited has been selected as the lead manager for the IPO.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.